-

Orfit® Aerial® Couch Top for Proton Therapy Validated by Mevion Medical Systems

LITTLETON, Mass.--(BUSINESS WIRE)--Today, Mevion Medical Systems and Orfit Industries are pleased to announce that the Aerial® Couch Top is validated for use on the MEVION S250® Series Proton Therapy Systems.

“Mevion is committed to providing customizable and complementary immobilization products to our customers and we are excited to partner with Orfit to add the Aerial Couch Top and accessories to our proton therapy systems,” said Ying Xiong, vice president of product management at Mevion Medical Systems.

The Aerial Couch Top combines precise and reproducible immobilization with homogeneity over the entire treatment area. With no rails or other obstructions below the extension, this recently US FDA cleared couch top minimizes the air gap, improving penumbra and plan quality. Aerial extensions are available for extracranial treatment and brain, head, and neck treatments when used with Orfit HP PRO masks. The use of 3-points single layer HP PRO masks can reduce target margins to 1 mm.

“The design of the Aerial is in line with the highest technical and safety standards, without being overly complex, so that it helps assure the best possible clinical outcome for patients. This couch top perfectly pairs with advanced proton therapy systems, such as MEVION S250i,” states Emilie Cuypers, product manager radiation oncology at Orfit.

Together, we are pleased to make this entirely new couch top available as of September 2020 to current and future Mevion operated proton therapy centers.

About Mevion Medical Systems

Mevion Medical Systems, Inc. is the leading provider of compact proton therapy systems for use in radiation treatment for cancer patients. Mevion is based in Littleton, Massachusetts, with a presence in Europe and China. For more information, please visit www.mevion.com

Follow us on Twitter: @MevionMedical
Connect with us on LinkedIn: Mevion Medical Systems
Like Us on Facebook: MevionMedical

About Orfit

Orfit Industries brings high precision and comfort to the positioning and immobilization of cancer patients in Radiation Oncology. For more information, go to www.orfit.com or follow us @orfitindustries on LinkedIn, Instagram, Facebook and Twitter.

Contacts

Mevion Medical Systems Media Contact
Melanie Benton, Sr. Marketing Project Manager
mbenton@mevion.com
978-540-1551

Orfit Industries Media Contact
Chloé Cuypers, Marketing Communications
chloe.cuypers@orfit.com

Mevion Medical Systems


Release Versions

Contacts

Mevion Medical Systems Media Contact
Melanie Benton, Sr. Marketing Project Manager
mbenton@mevion.com
978-540-1551

Orfit Industries Media Contact
Chloé Cuypers, Marketing Communications
chloe.cuypers@orfit.com

Social Media Profiles
More News From Mevion Medical Systems

Carilion Clinic and Mevion Medical Systems Announce Plans to Bring Proton Therapy to Southwest Virginia

ROANOKE, Va. & LITTLETON, Mass.--(BUSINESS WIRE)--Carilion Clinic, a leading integrated health system serving western Virginia, and Mevion Medical Systems, the global leader in compact proton therapy, today announced a partnership to bring advanced proton therapy to the new Carilion Taubman Cancer Center, now under construction in Roanoke. A Regional Milestone in Cancer Care The new Carilion Taubman Cancer Center will transform how cancer care is delivered across Southwest Virginia, bringing to...

Loma Linda University Health, Pioneer of Hospital-Based Proton Therapy, Selects Mevion FIT System to Launch Next Era of Cancer Care

LOMA LINDA, Calif. & LITTLETON, Mass.--(BUSINESS WIRE)--Loma Linda University Health (LLUH), the institution that created the world's first hospital-based Proton Therapy Treatment Center in 1990, and Mevion Medical Systems, the leading provider of compact proton therapy solutions, today announced a historic partnership to install the MEVION S250-FIT Proton Therapy System™. This milestone represents both a clinical leap forward and a symbolic return to the front lines of innovation for LLUH, lau...

Mevion Medical Systems Announces FDA Clearance for MEVION S250-FIT™ Proton Therapy System

LITTLETON, Mass.--(BUSINESS WIRE)--Mevion Medical Systems today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for the MEVION S250-FIT™ Proton Beam Radiation Therapy System, marking a significant milestone in expanding access to proton therapy.  The MEVION S250-FIT is the first and only proton therapy system designed to seamlessly fit into a standard radiation therapy vault. By leveraging existing infrastructure, the MEVION S250-FIT system lowers barrier...
Back to Newsroom